Ardelyx
ARDX
#5133
Rank
โ‚น161.25 B
Marketcap
โ‚น652.77
Share price
8.69%
Change (1 day)
86.99%
Change (1 year)

Revenue for Ardelyx (ARDX)

Revenue in 2025 (TTM): โ‚น35.74 Billion

According to Ardelyx's latest financial reports the company's current revenue (TTM ) is โ‚น38.64 Billion. an increase over the revenue in the year 2024 that were of โ‚น28.61 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ardelyx from 2013 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น36.56 B27.76%
2024 โ‚น28.61 B176.23%
2023 โ‚น10.36 B140.05%
2022 โ‚น4.31 B474.3%
2021 โ‚น0.75 B35.73%
2020 โ‚น0.55 B47.03%
2019 โ‚น0.37 B106.59%
2018 โ‚น0.18 B-93.2%
2017 โ‚น2.68 B
2016 N/A-100%
2015 โ‚น1.59 B-20.34%
2014 โ‚น2.00 B12.15%
2013 โ‚น1.78 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Abbott Laboratories
ABT
โ‚น4.205 T 10,782.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น3.486 T 8,922.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น5.116 T 13,138.17%๐Ÿ‡ซ๐Ÿ‡ท France
AstraZeneca
AZN
โ‚น5.573 T 14,320.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
OPKO Health
OPK
โ‚น60.91 B 57.63%๐Ÿ‡บ๐Ÿ‡ธ USA